VKTX Viking Therapeutics, Inc.
Company Analysis
Latest News
🔴 Viking Therapeutics is trading 5.0% down
Viking Therapeutics is trading at $35.43, down 5.0% from a comparison close of $37.31 during regular trading. This is a price-action follow-up, so a separate...
Viking Therapeutics, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 22, 2026
Viking Therapeutics is expected to report a consensus EPS loss of $1.21 on zero revenue for the second quarter of 2026, with its current price of $33.80...
Viking Therapeutics faces self-dealing probe, law firm investigates fiduciary breaches
Kuehn Law, PLLC is investigating Viking Therapeutics, Inc. (VKTX) for potential breaches of fiduciary duty. The probe focuses on allegations of self-dealing by...
🔴 Viking Therapeutics is trading 4.23% down today amid a broad biotech selloff and sector-wide weakness
Viking Therapeutics is trading at $36.21 (-4.23%) as a broad biotech and growth-stock selloff pressures the sector, moving in line with wider weakness in risk...
🔴 Viking Therapeutics is trading 5.2% down today amid profit-taking and volatility
Viking Therapeutics is trading 5.2% down today at $39.01 amid profit-taking and normal biotech volatility following recent gains. • No fresh company-specific...
🔴 VKTX extends move to 5.2% down
VKTX is trading at $39.95, down 5.2% versus the comparison close of $42.13 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 VKTX is trading 4.1% down today on profit-taking after a sharp multi-day rally
VKTX is trading at $40.40 (4.1% down), pulling back after a significant multi-day run-up and recent focus on its Q1 2026 earnings results. • The decline...
🟢 VKTX makes sharp 10.3% jump
VKTX is trading at $42.68, up 10.3% versus the comparison close of $38.71 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 VKTX is trading 3.6% up today after Piper Sandler reiterates Overweight rating and focus continues on VK3019 Phase 1 trial
• Viking Therapeutics (VKTX) shares are up 3.6% at $40.11, following a reiterated 'Overweight' rating and $71.00 price target from Piper Sandler. • The stock...
Analysts Debate Viking Therapeutics' Path to $50 Amid Weight-Loss Drug Optimism
An analysis published July 4th explores Viking Therapeutics' stock potential to reach $50. Viking Therapeutics' lead candidate, VK2735, drives optimism. This...
🔴 VKTX extends move to 5.1% down
VKTX is trading at $37.03, down 5.1% versus the comparison close of $39.01 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 VKTX is trading 4.08% down today as it gives back gains from its late-June rally
VKTX is trading at $37.42, down 4.08%, as the stock pulls back following a strong late-June rally driven by optimism surrounding its obesity-drug pipeline. •...
🟢 VKTX continues strong gains today as investors react to Phase 1 trial initiation for new obesity drug VK3019
Viking Therapeutics (VKTX) is up 4.2% today at $41.19, extending recent gains. • The continued momentum follows the company's announcement last week (June 24,...
🟢 VKTX extends move to 5.6% up
VKTX is trading at $36.76, up 5.6% versus the comparison close of $34.81 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 VKTX is trading 4.3% up today after initiating Phase 1 trial for new weight-loss drug VK3019
Viking Therapeutics Inc. (VKTX) is trading at $36.30 (4.3% up) today. • The company announced the initiation of a Phase 1 clinical trial for VK3019, an...
🟢 VKTX makes sharp 10.3% jump
VKTX is trading at $35.70, up 10.3% versus the comparison close of $32.37 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 VKTX extends move to 7.8% up
VKTX is trading at $34.90, up 7.8% versus the comparison close of $32.37 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 VKTX is trading 6.33% up today on takeover chatter and analyst optimism
VKTX is trading at $34.42 (6.33%) up today following fresh takeover chatter and continued analyst optimism. • CNBC recently flagged Viking Therapeutics as a...
🟢 VKTX Surges on Fresh Takeover Buzz and Analyst Optimism
• Viking Therapeutics (VKTX) is trading about 6% up at $32.20 in pre-market, continuing a sharp rebound. • The rally follows fresh takeover chatter after CNBC...
🟢 Viking Therapeutics, Inc. extends move to 5.1% up
VKTX is trading at $31.92, up 5.1% versus the comparison close of $30.38 during regular trading. This is a price-movement alert; no separate company-specific...